Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 406

1.

Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives.

Burggren AC, Shirazi A, Ginder N, London ED.

Am J Drug Alcohol Abuse. 2019 Jul 31:1-17. doi: 10.1080/00952990.2019.1634086. [Epub ahead of print]

PMID:
31365275
2.

Is (poly-) substance use associated with impaired inhibitory control? A mega-analysis controlling for confounders.

Liu Y, van den Wildenberg WPM, de Graaf Y, Ames SL, Baldacchino A, Ragnhild B, Cadaveira F, Campanella S, Christiansen P, Claus ED, Colzato LS, Filbey FM, Foxe JJ, Garavan H, Hendershot CS, Hester R, Jester JM, Karoly HC, Kräplin A, Kreusch F, Landrø NI, Littel M, Steins-Loeber S, London ED, López-Caneda E, Lubman DI, Luijten M, Marczinski CA, Metrik J, Montgomery C, Papachristou H, Mi Park S, Paz AL, Petit G, Prisciandaro JJ, Quednow BB, Ray LA, Roberts CA, Roberts GMP, de Ruiter MB, Rupp CI, Steele VR, Sun D, Takagi M, Tapert SF, Holst RJV, Verdejo-Garcia A, Vonmoos M, Wojnar M, Yao Y, Yücel M, Zack M, Zucker RA, Huizenga HM, Wiers RW.

Neurosci Biobehav Rev. 2019 Jul 15. pii: S0149-7634(18)30633-X. doi: 10.1016/j.neubiorev.2019.07.006. [Epub ahead of print] Review.

3.

Baseline impulsivity may moderate L-DOPA effects on value-based decision-making.

Petzold J, Kienast A, Lee Y, Pooseh S, London ED, Goschke T, Smolka MN.

Sci Rep. 2019 Apr 4;9(1):5652. doi: 10.1038/s41598-019-42124-x.

4.

Effects of Citalopram on Cue-Induced Alcohol Craving and Thalamic D2/3 Dopamine Receptor Availability.

Zorick T, Okita K, Mandelkern MA, London ED, Brody AL.

Int J Neuropsychopharmacol. 2019 Apr 1;22(4):286-291. doi: 10.1093/ijnp/pyz010.

5.

Addiction and Dopamine: Sex Differences and Insights from Studies of Smoking.

Petersen N, London ED.

Curr Opin Behav Sci. 2018 Oct;23:150-159. doi: 10.1016/j.cobeha.2018.07.002. Epub 2018 Jul 27.

PMID:
30746429
6.

Subregional Hippocampal Thickness Abnormalities in Older Adults with a History of Heavy Cannabis Use.

Burggren AC, Siddarth P, Mahmood Z, London ED, Harrison TM, Merrill DA, Small GW, Bookheimer SY.

Cannabis Cannabinoid Res. 2018 Dec 10;3(1):242-251. doi: 10.1089/can.2018.0035. eCollection 2018.

7.

Single high-dose buprenorphine for opioid craving during withdrawal.

Ahmadi J, Jahromi MS, Ghahremani D, London ED.

Trials. 2018 Dec 10;19(1):675. doi: 10.1186/s13063-018-3055-z.

8.

No effect of attentional bias modification training in methamphetamine users receiving residential treatment.

Dean AC, Nurmi EL, Moeller SJ, Amir N, Rozenman M, Ghahremani DG, Johnson M, Berberyan R, Hellemann G, Zhang Z, London ED.

Psychopharmacology (Berl). 2019 Feb;236(2):709-721. doi: 10.1007/s00213-018-5100-8. Epub 2018 Nov 10.

PMID:
30415277
9.

Effect of overnight smoking abstinence on a marker for microglial activation: a [11C]DAA1106 positron emission tomography study.

Brody AL, Gehlbach D, Garcia LY, Enoki R, Hoh C, Vera D, Kotta KK, London ED, Okita K, Nurmi EL, Seaman LC, Mandelkern MA.

Psychopharmacology (Berl). 2018 Dec;235(12):3525-3534. doi: 10.1007/s00213-018-5077-3. Epub 2018 Oct 20.

PMID:
30343364
10.

Neural basis of smoking-induced relief of craving and negative affect: Contribution of nicotine.

Faulkner P, Ghahremani DG, Tyndale RF, Paterson NE, Cox C, Ginder N, Hellemann G, London ED.

Addict Biol. 2019 Sep;24(5):1087-1095. doi: 10.1111/adb.12679. Epub 2018 Oct 11.

PMID:
30307083
11.

Functional Connectivity of the Raphe Nuclei: Link to Tobacco Withdrawal in Smokers.

Faulkner P, Ghahremani DG, Tyndale RF, Hellemann G, London ED.

Int J Neuropsychopharmacol. 2018 Sep 1;21(9):800-808. doi: 10.1093/ijnp/pyy054.

12.

N-Acetyl and Glutamatergic Neurometabolites in Perisylvian Brain Regions of Methamphetamine Users.

Tang J, O'Neill J, Alger JR, Shen Z, Johnson MC, London ED.

Int J Neuropsychopharmacol. 2019 Jan 1;22(1):1-9. doi: 10.1093/ijnp/pyy042.

13.

Cognitive deficit in methamphetamine users relative to childhood academic performance: link to cortical thickness.

Dean AC, Morales AM, Hellemann G, London ED.

Neuropsychopharmacology. 2018 Jul;43(8):1745-1752. doi: 10.1038/s41386-018-0065-1. Epub 2018 Apr 20.

14.

Multivariate Pattern Analysis of Genotype-Phenotype Relationships in Schizophrenia.

Zheutlin AB, Chekroud AM, Polimanti R, Gelernter J, Sabb FW, Bilder RM, Freimer N, London ED, Hultman CM, Cannon TD.

Schizophr Bull. 2018 Aug 20;44(5):1045-1052. doi: 10.1093/schbul/sby005.

PMID:
29534239
15.

Behavioral and neural markers of cigarette-craving regulation in young-adult smokers during abstinence and after smoking.

Ghahremani DG, Faulkner P, M Cox C, London ED.

Neuropsychopharmacology. 2018 Jun;43(7):1616-1622. doi: 10.1038/s41386-018-0019-7. Epub 2018 Feb 5.

16.

Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [11C]DAA1106 Positron Emission Tomography Study.

Brody AL, Hubert R, Enoki R, Garcia LY, Mamoun MS, Okita K, London ED, Nurmi EL, Seaman LC, Mandelkern MA.

Neuropsychopharmacology. 2018 Mar;43(4):925. doi: 10.1038/npp.2017.261.

17.

Brain activation during emotion regulation in women with premenstrual dysphoric disorder.

Petersen N, Ghahremani DG, Rapkin AJ, Berman SM, Liang L, London ED.

Psychol Med. 2018 Aug;48(11):1795-1802. doi: 10.1017/S0033291717003270. Epub 2017 Nov 17.

PMID:
29145910
18.

Sex differences in tobacco withdrawal and responses to smoking reduced-nicotine cigarettes in young smokers.

Faulkner P, Petersen N, Ghahremani DG, Cox CM, Tyndale RF, Hellemann GS, London ED.

Psychopharmacology (Berl). 2018 Jan;235(1):193-202. doi: 10.1007/s00213-017-4755-x. Epub 2017 Oct 11.

PMID:
29022071
19.

Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users.

Okita K, Morales AM, Dean AC, Johnson MC, Lu V, Farahi J, Mandelkern MA, London ED.

Mol Psychiatry. 2018 May;23(5):1320-1327. doi: 10.1038/mp.2017.172. Epub 2017 Sep 12.

20.

Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health.

Weinstein AM, Rosca P, Fattore L, London ED.

Front Psychiatry. 2017 Aug 23;8:156. doi: 10.3389/fpsyt.2017.00156. eCollection 2017. Review.

21.

Neural underpinnings of maladaptive decision-making in addictions.

Guttman Z, Moeller SJ, London ED.

Pharmacol Biochem Behav. 2018 Jan;164:84-98. doi: 10.1016/j.pbb.2017.06.014. Epub 2017 Jun 27. Review. No abstract available.

22.

Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users.

Moeller SJ, Okita K, Robertson CL, Ballard ME, Konova AB, Goldstein RZ, Mandelkern MA, London ED.

Neuropsychopharmacology. 2018 Mar;43(4):751-760. doi: 10.1038/npp.2017.138. Epub 2017 Jun 30.

23.

Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder.

Roche DJO, Worley MJ, Courtney KE, Bujarski S, London ED, Shoptaw S, Ray LA.

Psychopharmacology (Berl). 2017 Jul;234(13):1997-2007. doi: 10.1007/s00213-017-4607-8. Epub 2017 Mar 29.

24.

Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [11C]DAA1106 Positron Emission Tomography Study.

Brody AL, Hubert R, Enoki R, Garcia LY, Mamoun MS, Okita K, London ED, Nurmi EL, Seaman LC, Mandelkern MA.

Neuropsychopharmacology. 2017 Jul;42(8):1630-1639. doi: 10.1038/npp.2017.48. Epub 2017 Mar 6. Erratum in: Neuropsychopharmacology. 2018 Mar;43(4):925.

25.

Stages of dysfunctional decision-making in addiction.

Verdejo-Garcia A, Chong TT, Stout JC, Yücel M, London ED.

Pharmacol Biochem Behav. 2018 Jan;164:99-105. doi: 10.1016/j.pbb.2017.02.003. Epub 2017 Feb 16. Review.

PMID:
28216068
26.

A neural network that links brain function, white-matter structure and risky behavior.

Kohno M, Morales AM, Guttman Z, London ED.

Neuroimage. 2017 Apr 1;149:15-22. doi: 10.1016/j.neuroimage.2017.01.058. Epub 2017 Jan 25.

27.

Reduced-Nicotine Cigarettes in Young Smokers: Impact of Nicotine Metabolism on Nicotine Dose Effects.

Faulkner P, Ghahremani DG, Tyndale RF, Cox CM, Kazanjian AS, Paterson N, Lotfipour S, Hellemann GS, Petersen N, Vigil C, London ED.

Neuropsychopharmacology. 2017 Jul;42(8):1610-1618. doi: 10.1038/npp.2017.18. Epub 2017 Jan 24.

28.

A phenome-wide examination of neural and cognitive function.

Poldrack RA, Congdon E, Triplett W, Gorgolewski KJ, Karlsgodt KH, Mumford JA, Sabb FW, Freimer NB, London ED, Cannon TD, Bilder RM.

Sci Data. 2016 Dec 6;3:160110. doi: 10.1038/sdata.2016.110.

29.

Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users.

Kohno M, Okita K, Morales AM, Robertson CL, Dean AC, Ghahremani DG, Sabb FW, Rawson RA, Mandelkern MA, Bilder RM, London ED.

Mol Psychiatry. 2016 Nov;21(11):1554-1560. doi: 10.1038/mp.2015.223. Epub 2016 Feb 2.

30.

Cigarette Use and Striatal Dopamine D2/3 Receptors: Possible Role in the Link between Smoking and Nicotine Dependence.

Okita K, Mandelkern MA, London ED.

Int J Neuropsychopharmacol. 2016 Dec 3;19(11). pii: pyw074. doi: 10.1093/ijnp/pyw074. Print 2016 Nov.

31.

Mixture models of delay discounting and smoking behavior.

Hofmeyr A, Monterosso J, Dean AC, Morales AM, Bilder RM, Sabb FW, London ED.

Am J Drug Alcohol Abuse. 2017 May;43(3):271-280. doi: 10.1080/00952990.2016.1198797. Epub 2016 Jul 20.

PMID:
27439543
32.

Increased self-reported impulsivity in methamphetamine users maintaining drug abstinence.

Jones HW, Dean AC, Price KA, London ED.

Am J Drug Alcohol Abuse. 2016 Sep;42(5):500-506. Epub 2016 Jul 11.

33.

Sex Differences in Midbrain Dopamine D2-Type Receptor Availability and Association with Nicotine Dependence.

Okita K, Petersen N, Robertson CL, Dean AC, Mandelkern MA, London ED.

Neuropsychopharmacology. 2016 Nov;41(12):2913-2919. doi: 10.1038/npp.2016.105. Epub 2016 Jun 22.

34.

Impulsivity, Stimulant Abuse, and Dopamine Receptor Signaling.

London ED.

Adv Pharmacol. 2016;76:67-84. doi: 10.1016/bs.apha.2016.01.002. Epub 2016 Mar 2. Review.

PMID:
27288074
35.

Emotion regulation in women with premenstrual dysphoric disorder.

Petersen N, London ED, Liang L, Ghahremani DG, Gerards R, Goldman L, Rapkin AJ.

Arch Womens Ment Health. 2016 Oct;19(5):891-8. doi: 10.1007/s00737-016-0634-4. Epub 2016 May 7.

36.

Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine users.

Okita K, Ghahremani DG, Payer DE, Robertson CL, Dean AC, Mandelkern MA, London ED.

Drug Alcohol Depend. 2016 Apr 1;161:163-70. doi: 10.1016/j.drugalcdep.2016.01.029. Epub 2016 Feb 12.

37.

Genetic imaging consortium for addiction medicine: From neuroimaging to genes.

Mackey S, Kan KJ, Chaarani B, Alia-Klein N, Batalla A, Brooks S, Cousijn J, Dagher A, de Ruiter M, Desrivieres S, Feldstein Ewing SW, Goldstein RZ, Goudriaan AE, Heitzeg MM, Hutchison K, Li CS, London ED, Lorenzetti V, Luijten M, Martin-Santos R, Morales AM, Paulus MP, Paus T, Pearlson G, Schluter R, Momenan R, Schmaal L, Schumann G, Sinha R, Sjoerds Z, Stein DJ, Stein EA, Solowij N, Tapert S, Uhlmann A, Veltman D, van Holst R, Walter H, Wright MJ, Yucel M, Yurgelun-Todd D, Hibar DP, Jahanshad N, Thompson PM, Glahn DC, Garavan H, Conrod P.

Prog Brain Res. 2016;224:203-23. doi: 10.1016/bs.pbr.2015.07.026. Epub 2015 Nov 4. Review.

38.

A longitudinal mediational study on the stability of alexithymia among alcohol-dependent outpatients in cognitive-behavioral therapy.

Thorberg FA, Young RM, Sullivan KA, Lyvers M, Hurst CP, Connor JP, Tyssen R, London ED, Noble EP, Feeney GF.

Psychol Addict Behav. 2016 Feb;30(1):64-72. doi: 10.1037/adb0000135. Epub 2016 Jan 21.

PMID:
26795394
39.

Alexithymia in relation to alcohol expectancies in alcohol-dependent outpatients.

Thorberg FA, Young RM, Lyvers M, Sullivan KA, Hasking P, London ED, Tyssen R, Connor JP, Feeney GFX.

Psychiatry Res. 2016 Feb 28;236:186-188. doi: 10.1016/j.psychres.2016.01.016. Epub 2016 Jan 8.

PMID:
26775551
40.

Placebo analgesia: Self-report measures and preliminary evidence of cortical dopamine release associated with placebo response.

Jarcho JM, Feier NA, Labus JS, Naliboff B, Smith SR, Hong JY, Colloca L, Tillisch K, Mandelkern MA, Mayer EA, London ED.

Neuroimage Clin. 2015 Nov 14;10:107-14. doi: 10.1016/j.nicl.2015.11.009. eCollection 2016.

41.

Neuroimaging markers of glutamatergic and GABAergic systems in drug addiction: Relationships to resting-state functional connectivity.

Moeller SJ, London ED, Northoff G.

Neurosci Biobehav Rev. 2016 Feb;61:35-52. doi: 10.1016/j.neubiorev.2015.11.010. Epub 2015 Dec 1. Review.

42.

Striatal Dopamine D2/D3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine Users.

Ballard ME, Dean AC, Mandelkern MA, London ED.

PLoS One. 2015 Dec 14;10(12):e0143510. doi: 10.1371/journal.pone.0143510. eCollection 2015.

43.

Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but Not Methamphetamine-Dependent Individuals.

Okita K, Ghahremani DG, Payer DE, Robertson CL, Mandelkern MA, London ED.

Int J Neuropsychopharmacol. 2016 Apr 29;19(5). pii: pyv129. doi: 10.1093/ijnp/pyv129. Print 2016 May.

44.

Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment.

Robertson CL, Ishibashi K, Chudzynski J, Mooney LJ, Rawson RA, Dolezal BA, Cooper CB, Brown AK, Mandelkern MA, London ED.

Neuropsychopharmacology. 2016 May;41(6):1629-36. doi: 10.1038/npp.2015.331. Epub 2015 Oct 27.

45.

Consequences of Adolescent Smoking: Cognitive Performance, Brain Function, and Policy Implications.

London ED.

Biol Psychiatry. 2015 Nov 1;78(9):596-7. doi: 10.1016/j.biopsych.2015.08.011. No abstract available.

PMID:
26434629
46.

Memory systems in schizophrenia: Modularity is preserved but deficits are generalized.

Haut KM, Karlsgodt KH, Bilder RM, Congdon E, Freimer NB, London ED, Sabb FW, Ventura J, Cannon TD.

Schizophr Res. 2015 Oct;168(1-2):223-30. doi: 10.1016/j.schres.2015.08.014. Epub 2015 Aug 20.

47.

Functional Genetic Variation in Dopamine Signaling Moderates Prefrontal Cortical Activity During Risky Decision Making.

Kohno M, Nurmi EL, Laughlin CP, Morales AM, Gail EH, Hellemann GS, London ED.

Neuropsychopharmacology. 2016 Feb;41(3):695-703. doi: 10.1038/npp.2015.192. Epub 2015 Jun 29.

48.

Midbrain dopamine D2/D3 receptor availability and drug craving are associated with mesocorticolimbic gray matter volume in methamphetamine users.

Morales AM, Kohno M, Robertson CL, Dean AC, Mandelkern MA, London ED.

Mol Psychiatry. 2015 Jun;20(6):658. doi: 10.1038/mp.2015.59. No abstract available.

PMID:
25993553
49.

Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users.

Morales AM, Kohno M, Robertson CL, Dean AC, Mandelkern MA, London ED.

Mol Psychiatry. 2015 Jun;20(6):764-71. doi: 10.1038/mp.2015.47. Epub 2015 Apr 21.

50.

Striatal D1- and D2-type dopamine receptors are linked to motor response inhibition in human subjects.

Robertson CL, Ishibashi K, Mandelkern MA, Brown AK, Ghahremani DG, Sabb F, Bilder R, Cannon T, Borg J, London ED.

J Neurosci. 2015 Apr 15;35(15):5990-7. doi: 10.1523/JNEUROSCI.4850-14.2015.

Supplemental Content

Loading ...
Support Center